Published in Biochem J on September 01, 1998
Structure of aminopeptidase N from Escherichia coli suggests a compartmentalized, gated active site. Proc Natl Acad Sci U S A (2006) 1.33
Glu-333 of nicastrin directly participates in gamma-secretase activity. J Biol Chem (2009) 1.30
Biochemical and enzymatic properties of the M1 family of aminopeptidases involved in the regulation of blood pressure. Heart Fail Rev (2007) 0.97
The role of multifunctional M1 metallopeptidases in cell cycle progression. Ann Bot (2011) 0.84
Structural and Functional Determinants of gamma-Secretase, an Intramembrane Protease Implicated in Alzheimer's Disease. Curr Genomics (2007) 0.84
Identification of threonine 348 as a residue involved in aminopeptidase A substrate specificity. J Biol Chem (2009) 0.83
The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A. Biochem J (2002) 0.83
Aminopeptidase B, a glucagon-processing enzyme: site directed mutagenesis of the Zn2+-binding motif and molecular modelling. BMC Biochem (2007) 0.81
Placental leucine aminopeptidase- and aminopeptidase A- deficient mice offer insight concerning the mechanisms underlying preterm labor and preeclampsia. J Biomed Biotechnol (2010) 0.78
The catalytic and protein-protein interaction domains are required for APM1 function. Plant Physiol (2010) 0.77
Structural origins for the loss of catalytic activities of bifunctional human LTA4H revealed through molecular dynamics simulations. PLoS One (2012) 0.75
Tma108, a putative M1 aminopeptidase, is a specific nascent chain-associated protein in Saccharomyces cerevisiae. Nucleic Acids Res (2016) 0.75
Structural basis for the inhibition of M1 family aminopeptidases by the natural product actinonin: Crystal structure in complex with E. coli aminopeptidase N. Protein Sci (2015) 0.75
Histidine 379 of human laeverin/aminopeptidase Q, a nonconserved residue within the exopeptidase motif, defines its distinctive enzymatic properties. J Biol Chem (2009) 0.75
Involvement of arginine 878 together with Ca2+ in mouse aminopeptidase A substrate specificity for N-terminal acidic amino-acid residues. PLoS One (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science (1977) 5.39
A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett (1989) 3.41
Families of zinc metalloproteases. FEBS Lett (1994) 3.40
Carboxypeptidase A: a protein and an enzyme. Adv Protein Chem (1971) 2.61
A general and rapid mutagenesis method using polymerase chain reaction. Gene (1990) 2.12
Complete amino acid sequence of human intestinal aminopeptidase N as deduced from cloned cDNA. FEBS Lett (1988) 1.59
Molecular cloning of the murine BP-1/6C3 antigen: a member of the zinc-dependent metallopeptidase family. Proc Natl Acad Sci U S A (1990) 1.54
Comparison of the structures of carboxypeptidase A and thermolysin. J Biol Chem (1977) 1.46
Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem (1984) 1.44
Molecular cloning and amino acid sequence of leukotriene A4 hydrolase. Proc Natl Acad Sci U S A (1987) 1.34
A mammalian peptidase specific for the hydrolysis of N-terminal alpha-L-glutamyl and aspartyl residues. Nature (1962) 1.27
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc Natl Acad Sci U S A (1993) 1.16
Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem (1996) 1.15
Structure determination and refinement of bovine lens leucine aminopeptidase and its complex with bestatin. J Mol Biol (1992) 1.14
Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta (1970) 1.12
Aminopeptidase A activity of the murine B-lymphocyte differentiation antigen BP-1/6C3. Proc Natl Acad Sci U S A (1991) 1.11
Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J Biol Chem (1991) 1.11
Molecular cloning and amino acid sequence of rat kidney aminopeptidase M: a member of a super family of zinc-metallohydrolases. Biochem Biophys Res Commun (1989) 1.09
Rat endothelin-converting enzyme-1 forms a dimer through Cys412 with a similar catalytic mechanism and a distinct substrate binding mechanism compared with neutral endopeptidase-24.11. Biochem J (1996) 1.03
Evidence that both arginine 102 and arginine 747 are involved in substrate binding to neutral endopeptidase (EC 3.4.24.11). J Biol Chem (1991) 1.02
Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol (1992) 1.02
Two-metal ion mechanism of bovine lens leucine aminopeptidase: active site solvent structure and binding mode of L-leucinal, a gem-diolate transition state analogue, by X-ray crystallography. Biochemistry (1995) 1.01
Aminopeptidase B from the rat testis is a bifunctional enzyme structurally related to leukotriene-A4 hydrolase. Proc Natl Acad Sci U S A (1997) 1.00
Histidine residue in the zinc-binding motif of aminopeptidase A is critical for enzymatic activity. Proc Natl Acad Sci U S A (1993) 0.95
Rat kidney glutamyl aminopeptidase (aminopeptidase A): molecular identity and cellular localization. Am J Physiol (1994) 0.95
Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family. J Biol Chem (1996) 0.94
Amino acid sequence deduced from a rat kidney cDNA suggests it encodes the Zn-peptidase aminopeptidase N. J Biol Chem (1989) 0.93
Study on aminopeptidase A. Histochemistry (1980) 0.93
Angiotensin metabolism by cerebral microvascular aminopeptidase A. Biochem Pharmacol (1988) 0.93
Molecular cloning of soluble aminopeptidases from Saccharomyces cerevisiae. Sequence analysis of aminopeptidase yscII, a putative zinc-metallopeptidase. Eur J Biochem (1991) 0.93
Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience (1997) 0.91
A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochem J (1997) 0.91
X-ray crystallographic determination of the structure of bovine lens leucine aminopeptidase complexed with amastatin: formulation of a catalytic mechanism featuring a gem-diolate transition state. Biochemistry (1993) 0.91
Molecular cloning and expression of rat liver aminopeptidase B. J Biol Chem (1996) 0.91
Differential inhibition of aminopeptidase A and aminopeptidase N by new beta-amino thiols. J Med Chem (1994) 0.89
Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. J Med Chem (1994) 0.88
cDNA cloning and expression of human glutamyl aminopeptidase (aminopeptidase A). Genomics (1993) 0.87
Cloning of a cDNA encoding an ectoenzyme that degrades thyrotropin-releasing hormone. Proc Natl Acad Sci U S A (1994) 0.85
The nucleotide sequence of the pepN gene and its over-expression in Escherichia coli. Gene (1986) 0.85
Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J Med Chem (1992) 0.84
Proteolytic fragmentation reveals the oligomeric and domain structure of porcine aminopeptidase A. Biochemistry (1997) 0.83
Inhibition of angiotensin III formation by thiol derivatives of acidic amino acids. Neuropeptides (1990) 0.82
3-Amino-2-tetralone derivatives: novel potent and selective inhibitors of aminopeptidase-M (EC 3.4.11.2). Arch Biochem Biophys (1994) 0.81
Re-refinement of the X-ray crystal structure of bovine lens leucine aminopeptidase complexed with bestatin. J Mol Biol (1993) 0.80
Inhibition of bovine lens leucine aminopeptidase by bestatin: number of binding sites and slow binding of this inhibitor. Biochemistry (1993) 0.78
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res (1992) 3.95
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem (1991) 3.22
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem (1991) 1.86
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem (1991) 1.65
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol (1997) 1.65
Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res (1983) 1.62
The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem (1995) 1.58
Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol (1986) 1.55
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab (1997) 1.52
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem (2001) 1.51
Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem (1996) 1.49
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest (1997) 1.48
Multiple forms of human renin. Purification and characterization. J Biol Chem (1979) 1.45
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol (1990) 1.43
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem (1992) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Maturation-dependent changes of angiotensin receptor expression in fowl. Am J Physiol Regul Integr Comp Physiol (2003) 1.41
Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res (2005) 1.39
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol (1995) 1.39
Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension (1994) 1.38
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension (1997) 1.31
Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension (1993) 1.29
Structure of human angiotensinogen gene. DNA (1989) 1.28
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Species distribution of testosterone-binding globulin. Biol Reprod (1973) 1.26
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (1994) 1.24
Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med (1991) 1.23
Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet (1997) 1.23
Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol (1996) 1.22
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett (1989) 1.22
Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab (1982) 1.22
Role of angiotensinogen in blood pressure homeostasis. Hypertension (1982) 1.21
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19
Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension (1996) 1.18
Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16
Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem (1980) 1.15
Molecular cloning of a mouse submaxillary gland renin cDNA fragment. Proc Natl Acad Sci U S A (1981) 1.15
Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem (1996) 1.15
Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol (1997) 1.13
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest (2000) 1.12
Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab (1971) 1.12
Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry (1986) 1.12
Cloning and expression pattern of EPAS1 in the chicken embryo. Colocalization with tyrosine hydroxylase. FEBS Lett (1999) 1.11
Cloning and expression of an evolutionary conserved single-domain angiotensin converting enzyme from Drosophila melanogaster. J Biol Chem (1995) 1.11
Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A (1999) 1.11
Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens (1997) 1.09
Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine. Br J Clin Pharmacol (1987) 1.09
Comment on "Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake". Science (2007) 1.08
Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol (1987) 1.08
Measurement of urinary kallikrein activity. Species differences in kinin production. Biochim Biophys Acta (1981) 1.08
Mapping of a first locus for autosomal dominant myxomatous mitral-valve prolapse to chromosome 16p11.2-p12.1. Am J Hum Genet (1999) 1.07
Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome. J Hypertens (1997) 1.07
Proteolytic release of human angiotensin-converting enzyme. Localization of the cleavage site. J Biol Chem (1993) 1.07
Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma. Br J Cancer (2004) 1.07
Distribution of apelin-synthesizing neurons in the adult rat brain. Neuroscience (2002) 1.06
The angiotensin receptor subtype AT1A predominates in rat forebrain areas involved in blood pressure, body fluid homeostasis and neuroendocrine control. Brain Res Mol Brain Res (1995) 1.06
Genetic analysis of the beta subunit of the epithelial Na+ channel in essential hypertension. Hypertension (1998) 1.06
Comparison of the antihypertensive and hormonal effects of a cardioselective beta-blocker, acebutolol, and diuretics in essential hypertension. Am J Med (1978) 1.05
The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension (1993) 1.05
Molecular cloning and nucleotide sequence of a human renin cDNA fragment. Nucleic Acids Res (1983) 1.05
Plasma concentration of testosterone, dihydrotestosterone, testosterone-oestradiol binding globulin, and pituitary gonadotrophins in the syndrome of male pseudo-hermaphroditism with testicular feminization. Acta Endocrinol (Copenh) (1972) 1.04
Expression of angiotensin II AT2 receptor mRNA during development of rat kidney and adrenal gland. Am J Physiol (1995) 1.03
Pharmacological inactivation of the endothelin type A receptor in the early chick embryo: a model of mispatterning of the branchial arch derivatives. Development (1998) 1.03
Angiotensin II type 2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension (1996) 1.03
A direct determination of plasma aldosterone. Steroids (1974) 1.02
Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension (1998) 1.02
Renin biosynthesis by human tumoral juxtaglomerular cells. Evidences for a renin precursor. J Clin Invest (1984) 1.02
Diagnosis and treatment of renin-secreting tumors. Report of three cases. Hypertension (1984) 1.01
The Drosophila melanogaster-related angiotensin-I-converting enzymes Acer and Ance--distinct enzymic characteristics and alternative expression during pupal development. Eur J Biochem (1998) 1.01
Radioimmunoassay of methionine- and leucine-enkephalins in regions of rat brain and comparison with endorphins estimated by a radioreceptor assay. J Neurochem (1978) 1.01
Molecular biology of the angiotensin I converting enzyme: I. Biochemistry and structure of the gene. J Hypertens (1993) 1.01
Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology (1998) 1.00
New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin Invest (1984) 1.00
Steroid hormone receptors. Vitam Horm (1975) 1.00
Direct radioimmunoassay of human renin. J Clin Endocrinol Metab (1979) 1.00
Hypertensive crisis in patient with phaeochromocytoma given metoclopramide. Lancet (1976) 0.99
The angiotensin converting enzyme in the kidney. J Hypertens Suppl (1989) 0.98
A novel distal enhancer confers chorionic expression on the human renin gene. J Biol Chem (1998) 0.98
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proc Natl Acad Sci U S A (1999) 0.98
Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation (1995) 0.97
Angiotensin III: a central regulator of vasopressin release and blood pressure. Trends Endocrinol Metab (2001) 0.97
A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet (2000) 0.97